DRL settles patent row with Vivus on weight management drug
The settlement permits DRL to begin selling a generic version of Qsymia from June 2025, or earlier under certain circumstances…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Arrow Pharmaceuticals acquires Amneal Pharmaceuticals in Australia
Arrow will incur an amount of AUD 17 million towards consideration, working capital and other estimated acquisition and…
NPPA, NADA app to help athletes identify prohibited medicines
The app will bridge the information asymmetry for athletes and help them to keep away from the prohibited substances
Drug pricing…
US FDA hikes fee for processing ANDA by $1 lakh for FY18
The hike was made under Generic Drug User Fee Amendments of 2017 (GDUFA II)
Citing high workload, the US Food and Drug…
Ajanta Pharma launches eletriptan hydrobromide tabs
Eletriptan hydrobromide tabs are indicated to treat headache
Ajanta Pharma has launched eletriptan hydrobromide tablets, used to…
IGMPI wins ASSOCHAM Services Excellence Award 2017
IGMPI was felicitated keeping in mind the fundamentally strong and resilient education and knowledge dissemination model
IGMPI…
DRL launches Cefixime for oral suspension
The drug is a generic version of Suprax, approved by the US FDA
Vyome Biosciences appoints Angelo Secci as Chief Medical Officer
He will be responsible for leading Vyome’s clinical development, including the clinical programme of lead molecule, VB 1953, for…
Jubilant Life gets US FDA nod for anti-inflammatory drug
Indomethacin capsules are used in the treatment of moderate to severe inflammation and reduce pain
DRL announces the launch of Cefixime in the US
It is a therapeutic equivalent generic version of Suprax
Danone India launches Neocate in India
Neocate is a hypoallergenic, amino acid-based formula (AAF) intended for use in dietary management of cow’s milk allergy
AMRIT Pharmacy opens its 100th outlet
The new AMRIT pharmacy was inaugurated by J P Nadda at the Indira Gandhi Medical College in Shimla
Affordable Medicines and…
Alembic Pharma sells formulations manufacturing facility to SEPL
The company has sold its formulations manufacturing facility at Baddi on slump sale basis
Alembic Pharmaceuticals has sold its…
Ministry of Law and Justice rejects pharma marketing rules
The rejection is a setback for public health groups that have been pushing for rules on marketing to curb bribery and corruption
Zydus Cadila to market anti-psychotic drug
The drug is used to treat schizophrenia and the manic symptoms of bipolar disorder, has received US FDA approval
Prega News partners with SpiceJet
Exclusive offers from booking tickets to inflight services will make expecting mothers' journey memorable
Prega News, the…
Lupin launches generic Seroquel XR tabs in US
It is indicated for the treatment of schizophrenia; acute manic or mixed episodes in bipolar I disorder
Glenmark receives ANDA approval for Triamcinolone Acetonide Ointment
It is the generic version of Kenalog Ointment, 0.1 per cent, of Mylan Pharmaceuticals
Eisai Pharma to cater to the Japanese market
Launches new anti-epileptic drug Fycompa (perampanel) in India
Eisai Pharmaceuticals, in order to cater to the Japanese market,…
DRL out-licenses DFD-06 to Encore Dermatology
The drug is intended to be used for treatment of moderate to severe plaque psoriasis.